Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 known ✓ | P22001 | 1/20 | 0.41 |
| ▸ | MAOA known ✓ | P21397 | 1/20 | 0.38 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.36 |
| ▸ | SRC known ✓ | P12931 | 1/20 | 0.36 |
| ▸ | MAOB known ✓ | P27338 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.38 |
| ▸ | BAX | Q07812 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3355123 | 1.00 | LTA4H (0.50) | LTA4HTSHRCA4KCNA3CA5A | |
| Hydrochloric Acid SCHEMBL1982434 | 1.00 | — | — | |
| SCHEMBL2476774 | 0.97 | — | — | |
| SCHEMBL3068689 | 0.93 | — | — | |
| Bromide SCHEMBL727799 | 0.93 | LTA4H (0.50) | LTA4HTSHRCA4KCNA3CA5A | |
| SCHEMBL3081684 | 0.93 | — | — | |
| Hydrochloric Acid SCHEMBL18340209 | 0.87 | CA4 (0.48) | LTA4HTSHRCA4KCNA3CA5A | |
| Hydrochloric Acid SCHEMBL4062895 | 0.77 | MAOA (0.43) | LTA4HMAOAALDH1A1MAOB | |
| SCHEMBL27503700 | 0.73 | MAOA (0.44) | LTA4HMAOAALDH1A1 | |
| Diphenylether SCHEMBL2859485 | 0.72 | LTA4H (0.92) | LTA4HTSHRCA4NR1H2BAX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 457 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118599118-A | Energy-saving and consumption-reducing poly (ether) sulfone and method for synthesizing block copolymer thereof | 山东净泽膜科技有限公司 | 2024-09-06 | — | — | CN | claimed |
| CN-117264215-A | Method for synthesizing polysulfone, polyether sulfone and segmented copolymer thereof by dehydration synchronous polymerization | 天津工业大学 | 2023-12-22 | — | — | CN | claimed |
| CN-114130212-A | Method for preparing separation membrane by using small molecule monomer | 天津工业大学 | 2022-03-04 | — | — | CN | claimed |
| EP-3050906-B1 | CATALYST PROCESS MODIFICATION AND POLYMERIZATION THEREOF | INDIAN OIL CORP LTD (IN) | 2020-07-22 | — | — | EP | claimed |
| EP-3653631-A1 | PROCESSES FOR THE PREPARATION OF AN OLEFIN POLYMERIZATION CATALYST BASED ON TREATING SOLID ORGANOMAGNESIUM COMPOUNDS WITH TITANIUM MOIETIES | INDIAN OIL CORPORATION Ltd. (IN) | 2020-05-20 | — | — | EP | claimed |
| EP-3018150-B1 | PROCESS FOR THE PREPARATION OF SPHERICAL CATALYST PARTICLES | INDIAN OIL CORP LTD (IN) | 2020-03-11 | — | — | EP | claimed |
| EP-2966099-B1 | PARTICLE SIZE DISTRIBUTION CONTROL THROUGH INTERNAL DONOR IN ZIEGLER-NATTA CATALYST | INDIAN OIL CORP LTD (IN) | 2020-03-11 | — | — | EP | claimed |
| EP-3543247-A1 | PRECURSOR FOR CATALYST, PROCESS FOR PREPARING THE SAME AND ITS USE THEREOF | INDIAN OIL CORPORATION Ltd. (IN) | 2019-09-25 | — | — | EP | claimed |
| US-10100136-B2 | Organometallic compound in solid form, process for preparing the same and use thereof | INDIAN OIL CORPORATION LIMITED (IN) | 2018-10-16 | — | — | US | claimed |
| EP-3059261-B1 | PROCESS FOR PREPARING A CATALYST FOR OLEFIN POLYMERIZATION AND POLYMERIZATION | INDIAN OIL CORP LTD (IN) | 2018-10-03 | — | — | EP | claimed |
| US-20150203604-A1 | CATALYST FOR POLYMERIZATION OF OLEFINS AND PROCESS THEREOF | INDIAN OIL CORPORATION LIMITED (IN) | 2015-07-23 | — | — | US | claimed |
| US-20150191553-A1 | ORGANOMETALLIC COMPOUND IN SOLID FORM, PROCESS FOR PREPARING THE SAME AND USE THEREOF | INDIAN OIL CORPORATION LIMITED (IN) | 2015-07-09 | — | — | US | claimed |
| WO-2014045260-A2 | ORGANOMETALLIC COMPOUND IN SOLID FORM, PROCESS FOR PREPARING THE SAME AND USE THEREOF | INDIAN OIL CORPORATION LIMITED (IN) | 2014-03-27 | — | — | WO | claimed |
| WO-2014045258-A2 | CATALYST FOR POLYMERIZATION OF OLEFINS AND PROCESS THEREOF | INDIAN OIL CORPORATION LIMITED (IN) | 2014-03-27 | — | — | WO | claimed |
| WO-2014045259-A2 | PRECURSOR FOR CATALYST, PROCESS FOR PREPARING THE SAME AND ITS USE THEREOF | INDIAN OIL CORPORATION LIMITED (IN) | 2014-03-27 | — | — | WO | claimed |
| EP-0539937-B1 | Process for producing olefin polymers | SUMITOMO CHEMICAL CO (JP) | 1996-09-18 | — | — | EP | claimed |
| US-5463000-A | Homopolymerizing or copolymerizing with alpha-olefin in gas phase using catalyst system | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-10-31 | — | — | US | claimed |
| EP-0539937-A1 | Process for producing olefin polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-05-05 | — | — | EP | claimed |
| US-4022958-A | Process for preparing polyolefins | NIPPON OIL COMPANY LTD. (JA) | 1977-05-10 | — | — | US | claimed |
| US-3991260-A | Process for preparing polyolefins | NIPPON OIL CORPORATION LTD. (JA) | 1976-11-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10100136-B2 | Organometallic compound in solid form, process for preparing the same and use thereof | MLX, BRIX1, CYP4X1 | KCNA3 785/4885MAOA 2602/4885CA2 724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.